GILD: Gilead Sciences Inc. Stocks News on September 8, 2025

Gilead Acquires Interius BioTherapeutics to Advance Next-Gen Cell Therapy

GILD

Insider Monkey

2 days ago

Gilead Acquires Interius BioTherapeutics to Advance Next-Gen Cell Therapy

Gilead Sciences advances HIV prevention with new US partnership

GILD

Pharmaceutical Technology

3 days ago

Gilead Sciences advances HIV prevention with new US partnership

The US will buy 2 million doses of an HIV prevention drug for low-income countries

GILD

Associated Press Finance

3 days ago

The US will buy 2 million doses of an HIV prevention drug for low-income countries

GILD

MT Newswires

3 days ago

Gilead Sciences Collaborates With PEPFAR to Make HIV Drug Lenacapavir Accessible Across Countries

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

GILD

Business Wire

3 days ago

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory

GILD

Insider Monkey

3 days ago

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory

Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer

GILD

GlobeNewswire

3 days ago

Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva

GILD

GlobeNewswire

3 days ago

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva

Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV

GILD

Business Wire Videos

4 days ago

Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV

GILD

Business Wire Videos

4 days ago

Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV

IDEAYA Biosciences Announces First-Patient-In for Phase 1/2 Combination Trial of IDE397, A Potential First-in-Class MAT2A Inhibitor, and Trodelvy® in MTAP-Deletion Non-Small Cell Lung Cancer

GILD

PR Newswire

4 days ago

IDEAYA Biosciences Announces First-Patient-In for Phase 1/2 Combination Trial of IDE397, A Potential First-in-Class MAT2A Inhibitor, and Trodelvy® in MTAP-Deletion Non-Small Cell Lung Cancer

Is Gilead Sciences Stock Underperforming the Nasdaq?

GILD

Barchart

4 days ago

Is Gilead Sciences Stock Underperforming the Nasdaq?

GILD

MT Newswires

4 days ago

Gilead Sciences Breaks Ground on New Manufacturing Center at California HQ

Gilead starts building manufacturing hub under $32 billion planned US investments

GILD

Reuters

4 days ago

Gilead starts building manufacturing hub under $32 billion planned US investments

Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy

GILD

Business Wire

4 days ago

Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy

1 Healthcare Stock to Consider Right Now and 2 We Question

GILD

StockStory

5 days ago

1 Healthcare Stock to Consider Right Now and 2 We Question

GILD

Insider Monkey

5 days ago

What Do Analysts Think About Gilead Sciences (GILD)?

GILD

Insider Monkey

6 days ago

Gilead Sciences, Inc. (GILD) Wins FDA Approval for World’s First Twice-Yearly HIV Preventive Therapy

Wyoming State Buys European Bank Stocks, Adjusts Healthcare Holdings

GILD

Barrons.com

7 days ago

Wyoming State Buys European Bank Stocks, Adjusts Healthcare Holdings

GILD

Insider Monkey

8 days ago

Gilead Sciences (GILD) Announces Marketing Authorization for Yeytuo from the European Commission

GILD

MT Newswires

9 days ago

Gilead Sciences Insider Sold Shares Worth $1,136,300, According to a Recent SEC Filing

GILD

Zacks

11 days ago

Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock

GILD

Simply Wall St.

12 days ago

The Bull Case For Gilead Sciences (GILD) Could Change Following European Approval of Twice-Yearly HIV Prevention Injection

GILD

Insider Monkey

12 days ago

Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock – Here’s Why

GILD

Argus Research

12 days ago

The Argus High-Yield Model Portfolio

GILD

Zacks

12 days ago

GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU

Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win

GILD

Investor's Business Daily

13 days ago

Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win

Gilead’s Yeytuo approved in EU, boosting its blockbuster potential

GILD

Pharmaceutical Technology

13 days ago

Gilead’s Yeytuo approved in EU, boosting its blockbuster potential

GILD

Investing.com

13 days ago

Gilead wins European approval for HIV prevention injection

GILD

MT Newswires

13 days ago

Gilead Sciences Says HIV Prevention Shot Yeytuo Approved in EU

European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention

GILD

Business Wire

13 days ago

European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention

GILD

Zacks

16 days ago

GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo

This Overlooked Biotech Stock Is a Buy for Its Hidden Strengths

GILD

Barchart

17 days ago

This Overlooked Biotech Stock Is a Buy for Its Hidden Strengths

Gilead’s Kite scoops in vivo CAR-T specialist Interius for $350m

GILD

Pharmaceutical Technology

17 days ago

Gilead’s Kite scoops in vivo CAR-T specialist Interius for $350m

Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug

GILD

Investor's Business Daily

17 days ago

Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug

GILD

MT Newswires

17 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

GILD

MT Newswires

17 days ago

Sector Update: Health Care

Gilead Needs Insurers to Cover New HIV Prevention Shot. CVS Isn’t Paying.

GILD

Barrons.com

17 days ago

Gilead Needs Insurers to Cover New HIV Prevention Shot. CVS Isn’t Paying.

GILD

StockStory

17 days ago

Why Gilead Sciences (GILD) Shares Are Sliding Today

Coty, Gilead Sciences, Rent the Runway: Trending tickers

GILD

Yahoo Finance Video

17 days ago

Coty, Gilead Sciences, Rent the Runway: Trending tickers

Stocks Pressured by Weak Walmart Earnings and Higher Bond Yields

GILD

Barchart

17 days ago

Stocks Pressured by Weak Walmart Earnings and Higher Bond Yields

Stock Market Today: Dow Jones Index Falls After Surprise Jobless Claims; Walmart Tumbles On Earnings Miss (Live Coverage)

GILD

Investor's Business Daily

17 days ago

Stock Market Today: Dow Jones Index Falls After Surprise Jobless Claims; Walmart Tumbles On Earnings Miss (Live Coverage)

GILD

MT Newswires

18 days ago

Gilead Sciences Unit to Acquire Interius BioTherapeutics for $350 Million

GILD

Investing.com

18 days ago

Gilead stock falls after CVS holds off adding HIV prevention shot to plans

Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform

GILD

Business Wire

18 days ago

Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform

Dow Jones Futures Fall Amid Walmart Earnings, Meta News After Palantir-Led Rally Off Lows

GILD

Investor's Business Daily

18 days ago

Dow Jones Futures Fall Amid Walmart Earnings, Meta News After Palantir-Led Rally Off Lows

GILD

MT Newswires

18 days ago

Market Chatter: CVS Health Won't Cover Gilead's New HIV Prevention Drug Yet

Exclusive-CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists

GILD

Reuters

18 days ago

Exclusive-CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists

Gilead Sciences to Present at Upcoming Investor Conferences

GILD

Business Wire

18 days ago

Gilead Sciences to Present at Upcoming Investor Conferences

BTS and clients recognized with 59 Brandon Hall Group Excellence Awards in 2025

GILD

Business Wire

19 days ago

BTS and clients recognized with 59 Brandon Hall Group Excellence Awards in 2025

GILD

MT Newswires

19 days ago

Bernstein Adjusts Price Target on Gilead Sciences to $135 From $120, Maintains Outperform Rating

GILD

MT Newswires

19 days ago

Walgreens Specialty Pharmacy Expands Limited Distribution Network

GILD

MT Newswires

20 days ago

Daiwa Upgrades Gilead Sciences to Outperform From Neutral, Adjusts Price Target to $128 From $104

GILD

MT Newswires

20 days ago

Gilead Sciences Insider Sold Shares Worth $3,318,927, According to a Recent SEC Filing

GILD

Zacks

21 days ago

GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait?

GILD

MT Newswires

21 days ago

Argus Adjusts Price Target on Gilead Sciences to $130 From $120

GILD

Argus Research

21 days ago

Analyst Report: Gilead Sciences, Inc.

GILD

Argus Research

21 days ago

Market Digest: CHH, GILD, HOLX, WTRG, FTV, FOXA, OTIS, DUOL, RDDT

GILD

MT Newswires

21 days ago

Mizuho Adjusts Price Target on Gilead Sciences to $131 From $117, Maintains Outperform Rating

GILD

Barchart

22 days ago

The Saturday Spread: These 3 Stocks Statistically May Be Cooking Up Something Special (GILD, WMB, XPEV)

GILD

Zacks

24 days ago

Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?

GILD

Simply Wall St.

25 days ago

We Think Gilead Sciences' (NASDAQ:GILD) Profit Is Only A Baseline For What They Can Achieve

Gilead Sciences’s Q2 Earnings Call: Our Top 5 Analyst Questions

GILD

StockStory

25 days ago

Gilead Sciences’s Q2 Earnings Call: Our Top 5 Analyst Questions

GILD

StockStory

25 days ago

Q2 Rundown: Gilead Sciences (NASDAQ:GILD) Vs Other Therapeutics Stocks

GILD

Argus Research

a month ago

Technical Assessment: Bullish in the Intermediate-Term

GILD

MT Newswires

a month ago

Market Chatter: Eli Lilly, Pfizer Among Drugmakers Eyeing a Spot in Chinese Commercial Health Insurance Catalog

GILD

StockStory

a month ago

GILD Q2 Deep Dive: HIV Franchise Drives Growth, New Launches and Pipeline in Focus

Gilead Receives Favorable CHMP Opinion For HIV Prevention With Twice-Yearly Lenacapavir

GILD

Insider Monkey

a month ago

Gilead Receives Favorable CHMP Opinion For HIV Prevention With Twice-Yearly Lenacapavir

GILD

MT Newswires

a month ago

Rothschild & Co Redburn Adjusts Price Target on Gilead Sciences to $136 From $132

3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

GILD

Zacks

a month ago

3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

GILD

MT Newswires

a month ago

Deutsche Bank Adjusts Gilead Sciences Price Target to $135 From $120, Maintains Buy Rating

Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update

GILD

GlobeNewswire

a month ago

Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update

GILD

Zacks

a month ago

Company News for Aug 11, 2025

Gilead Stock Is Closing In on an All-Time High. The Case for More Upside.

GILD

Barrons.com

a month ago

Gilead Stock Is Closing In on an All-Time High. The Case for More Upside.

GILD

Insider Monkey

a month ago

Gilead Sciences (GILD) Touches New Record High as 10 Analysts Turn Bullish

Gilead Sciences Second Quarter 2025 Earnings: Beats Expectations

GILD

Simply Wall St.

a month ago

Gilead Sciences Second Quarter 2025 Earnings: Beats Expectations

Nasdaq posts record closing high with tech gains, rate cut optimism

GILD

Reuters Videos

a month ago

Nasdaq posts record closing high with tech gains, rate cut optimism

S&P 500 Gains and Losses Today: Apple Stock Extends Its Rise; The Trade Desk Craters After Earnings

GILD

Investopedia

a month ago

S&P 500 Gains and Losses Today: Apple Stock Extends Its Rise; The Trade Desk Craters After Earnings

GILD

MT Newswires

a month ago

Equity Markets Close Higher After Earnings, Fed's Musalem Inflation, Labor Remarks

These Stocks Moved the Most Today: Trade Desk, Expedia, SoundHound, Pinterest, Gilead, Peloton, and More

GILD

Barrons.com

a month ago

These Stocks Moved the Most Today: Trade Desk, Expedia, SoundHound, Pinterest, Gilead, Peloton, and More

GILD

Associated Press

a month ago

How major US stock indexes fared Friday, 8/8/2025

GILD

MT Newswires

a month ago

US Equity Markets Rise, Nasdaq Climbs to Record After Week Packed With Corporate Earnings

Gilead Surges 8%, Flirting With A Breakout, On Growing Enthusiasm For HIV PrEP

GILD

Investor's Business Daily

a month ago

Gilead Surges 8%, Flirting With A Breakout, On Growing Enthusiasm For HIV PrEP

GILD

MT Newswires

a month ago

Equity Markets Rise After Corporate Earnings; Fed's Musalem Sees Labor, Inflation Risks

Stock Market Today: Dow Rises, But Under Armour Plunges On This Warning (Live Coverage)

GILD

Investor's Business Daily

a month ago

Stock Market Today: Dow Rises, But Under Armour Plunges On This Warning (Live Coverage)

GILD

MT Newswires

a month ago

UBS Raises Price Target on Gilead Sciences to $112 From $108, Maintains Neutral Rating

GILD

MT Newswires

a month ago

Assembly Biosciences Prices 5.6 Million Shares; Gilead to Buy 2.3 Million Shares in Private Offering

GILD

MT Newswires

a month ago

JPMorgan Adjusts Price Target on Gilead Sciences to $135 From $130, Maintains Overweight Rating

GILD

MT Newswires

a month ago

Baird Adjusts Price Target on Gilead Sciences to $108 From $100, Maintains Neutral Rating

GILD

MT Newswires

a month ago

BMO Capital Adjusts Price Target on Gilead Sciences to $130 From $120, Maintains Outperform Rating

GILD

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on Gilead Sciences to $105 From $100, Maintains Neutral Rating

GILD

MT Newswires

a month ago

TD Cowen Adjusts Price Target on Gilead Sciences to $115 From $110, Maintains Buy Rating

Stocks Gain Pre-Bell as Trump's Sweeping New Tariffs Take Effect; Investors Assess Apple's $600 Billion US Investment Plan

GILD

MT Newswires

a month ago

Stocks Gain Pre-Bell as Trump's Sweeping New Tariffs Take Effect; Investors Assess Apple's $600 Billion US Investment Plan

GILD

PR Newswire

a month ago

Compugen Reports Second Quarter 2025 Results

GILD

StockStory

a month ago

Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of Earnings

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?

GILD

Investor's Business Daily

a month ago

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

GILD

Zacks

a month ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

GILD

Zacks

a month ago

Seeking Clues to Gilead (GILD) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

GILD

Zacks

a month ago

GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock?

GILD

MT Newswires

a month ago

Latest Gilead Sciences Inc. (GILD) News on September 8, 2025

Share on Social Networks: